NOF Corp stock (JP3203500008): Q4 2025 earnings release and dividend announcement

NOF Corp released Q4 2025 results on May 11, 2026, alongside a 35 JPY dividend payable to shareholders of record March 31, 2027. The Japanese chemicals firm saw its shares rise 0.34% to 4,693 JPY on May 11.

NOF Corp, a leading Japanese chemicals and pharmaceuticals manufacturer, published its fiscal Q4 2025 earnings on May 11, 2026, according to Finanzen.net as of 05/11/2026. The company also announced a dividend of 35 JPY per share, with ex-dividend date set for March 30, 2027, as reported by Moomoo as of 05/12/2026. Shares closed at 4,693 JPY on the Tokyo Stock Exchange on May 11, up 16 JPY or 0.34%, per JPX data as of 05/11/2026.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: NOF Corp
• Sector/industry: Chemicals and Pharmaceuticals
• Headquarters/country: Japan
• Core markets: Asia, Europe
• Key revenue drivers: Peroxides, propellants, pharma products
• Home exchange/listing venue: Tokyo Stock Exchange (4403)
• Trading currency: JPY

NOF Corp: core business model

NOF Corp specializes in the production of peroxides, a key chemical used in polymerization processes for plastics and resins, as well as in pharmaceuticals and aerospace propellants. The company operates through three main segments: Chemicals, Pharmaceuticals, and Others, according to its investor relations site NOF IR as of 05/12/2026. Headquartered in Tokyo, Japan, NOF maintains a global footprint with production facilities in Asia and Europe.

Its chemicals division focuses on organic peroxides essential for manufacturing polyethylene and polypropylene, materials critical to packaging and automotive industries. The pharmaceuticals arm develops drug delivery systems and biopharmaceuticals, targeting growth in biologics. This diversified model provides stability amid cyclical chemical markets.

Main revenue and product drivers for NOF Corp

Peroxides remain NOF Corp's largest revenue contributor, driven by demand from Asia's expanding plastics sector. The company reported steady demand in its latest filings, with Q4 2025 results highlighting resilience in core chemical sales published on May 11, 2026, per Finanzen.net as of 05/11/2026. Pharmaceutical products, including lipid nanoparticles for mRNA vaccines, have gained traction post-pandemic.

Aerospace and defense propellants form a high-margin niche, benefiting from Japan's defense spending increases. The announced 35 JPY dividend reflects confidence in cash flow generation from these drivers, payable to record holders on March 31, 2027.

Industry trends and competitive position

The global peroxides market is projected to grow with rising polymer demand, where NOF Corp holds a leading position in Asia, as noted in Ad-hoc-News as of recent publication. Competitors include AkzoNobel and Solvay, but NOF's integrated production gives cost advantages in Japan.

In pharmaceuticals, NOF benefits from Japan's biotech push, supplying excipients to global firms. Sustainability trends favor its eco-friendly peroxide formulations amid tightening regulations.

Why NOF Corp matters for US investors

US investors gain exposure to Japan's chemicals sector via NOF Corp's OTC trading and supply chain links to American multinationals in plastics and pharma. With unsponsored ADRs noted on May 11, 2026, per Finanzen.net, it offers diversification into Asia-Pacific growth. The firm's role in vaccine tech ties into US healthcare innovation.

Conclusion

NOF Corp's Q4 2025 earnings and 35 JPY dividend announcement underscore operational strength in chemicals and pharma amid positive share momentum on May 11, 2026. Investors track its peroxide leadership and biotech expansion for insights into industrial trends. Future catalysts include full-year guidance and ex-dividend impacts.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.